Anika (ANIK) Earnings
October 28, 2009 · Filed Under Financial
Anika Therapeutics (NASDAQ:ANIK) is not much of a company. It has a market cap of $81 million.
Total revenue for the third quarter of 2009 increased 17% to $10,793,000 from $9,205,000 in the third quarter of 2008, a very modest increase.
Net income for the third quarter of 2009 grew 37% to $1,512,000, or $0.13 per diluted share, from $1,104,000, or $0.10 per diluted share, for the same period last year.
The news pusshed ANIK shares higher to 13% to $7.16.
Douglas A. McIntyre
Comments
Latest from 247Wallst.com- One-Time Dividends Today Versus Past (GRMN, LTD, MSFT, AXE, INSP)
- World Bank Downplays China Inflation
- Public Offering Floodgates Open Wide (CUZ, DHX, DFS, EPR, FNSR, FPO, GEL, G, GLP, HIG, IRDM, LXRX, NVAX, ORG, SATC, TTMI)
- Today’s Best Market Rumors (3/17/2010)
- Top Analyst Upgrades and Downgrades (ALU, ANN, ATHN, ADSK, BHP, BRCM, CTXS, DO, GHL, MRVL, ERIC)
- Latest from VSInvestor
- Exponential Volume Club (AKNS, BBI, FNM, FUQI, LSI, VIVO, PLCM, SNV, VHC, VLTR)
- Top Day Trader Alerts (ERIC, CIT, FUQI, GGP, PLCM, HOG, GE, ABK)
- Rumors Drive Volume (GGP, SPG, HOG)
- Stock/Option Explosion: The GE Breakout on 52-Week Highs (GE)
- Top Day Trader Alerts (ICGN, SQNM, MPEL, ATHN, BSX, MCHP, GE)
